| Heidi Anna May, CNM, ANP | |
|
1919 Lathrop St Ste 222, Fairbanks, AK 99701-5942 | |
| (907) 456-8191 | |
| (907) 456-8192 |
| Full Name | Heidi Anna May |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1919 Lathrop St Ste 222, Fairbanks, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710402805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 124397 (Alaska) | Primary |
| Entity Name | Chena Obstetrics & Gynecology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639271323 PECOS PAC ID: 5193827806 Enrollment ID: O20070227000610 |
News Archive
For patients with painful swelling of the legs caused by chronic venous insufficiency (CVI), a combination treatment approach called "complete decongestive physiotherapy" improves symptoms, walking ability, and quality of life, reports a study in Topics in Geriatric Rehabilitation.
Converge, MEDSEEK's eHealth Strategy group, will host its second annual eHealth Council in Savannah, Georgia on September 30 and October 1, 2010. eHealth Council is open to healthcare executives and thought leaders from across the country who are interested in interacting with peers and gathering information and best practices around eHealth.
Plant biologists at the Max Planck Institute of Developmental Biology and the University of North Carolina at Chapel Hill have discovered that an autoimmune response, triggered by a small number of genes, can be a barrier to producing a viable offspring.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidi Anna May, CNM, ANP 1919 Lathrop St Ste 222, Fairbanks, AK 99701-5942 Ph: (907) 456-8191 | Heidi Anna May, CNM, ANP 1919 Lathrop St Ste 222, Fairbanks, AK 99701-5942 Ph: (907) 456-8191 |
News Archive
For patients with painful swelling of the legs caused by chronic venous insufficiency (CVI), a combination treatment approach called "complete decongestive physiotherapy" improves symptoms, walking ability, and quality of life, reports a study in Topics in Geriatric Rehabilitation.
Converge, MEDSEEK's eHealth Strategy group, will host its second annual eHealth Council in Savannah, Georgia on September 30 and October 1, 2010. eHealth Council is open to healthcare executives and thought leaders from across the country who are interested in interacting with peers and gathering information and best practices around eHealth.
Plant biologists at the Max Planck Institute of Developmental Biology and the University of North Carolina at Chapel Hill have discovered that an autoimmune response, triggered by a small number of genes, can be a barrier to producing a viable offspring.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
Georgann Mcbrayer, MSN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 930 Ellesmere Dr, Fairbanks, AK 99709 Phone: 505-400-9293 Fax: 505-400-9293 | |
Matthew Petcoff, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-451-6682 | |
Julie Moon, CNM, ARNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2054 30th Ave, Fairbanks, AK 99701 Phone: 907-456-3719 | |
Caroline Tautz Hutto, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3550 Airport Way Ste 4, Fairbanks, AK 99709 Phone: 907-479-2331 | |
Amanda Joy Cushing, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-452-8251 | |
Ms. Clarissa Lynn Christensen, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1867 Airport Way Ste 160b, Fairbanks, AK 99701 Phone: 800-769-0045 Fax: 206-788-8339 | |
Courtney Michelle Amundson, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1919 Lathrop St Ste 222, Fairbanks, AK 99701 Phone: 907-456-8191 |